| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SIENTRA Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 244,30 | +0,25 % | Dividendenbekanntmachungen (09.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANSIX INC US00773T1016 0,16 USD 0,1377 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2496 EUR ALPHABET INC CDR CA02080K1049 0... ► Artikel lesen | |
| THERMO FISHER | 436,95 | -0,56 % | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| TELADOC HEALTH | 4,964 | +8,36 % | BofA raises Teladoc stock price target on virtual therapy M&A | ||
| ROKU | 85,57 | -0,60 % | Is Roku Stock a Buy as Platform Revenues and ARPU Improve? | ||
| RESMED | 217,50 | -0,18 % | Resmed, Inc.: Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach | Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
53% of people surveyed rank sleep as the most important behavior for a long... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA 7300,B0Y,YAG: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZEROSTACK CORP.... ► Artikel lesen | |
| HENRY SCHEIN | 65,90 | -2,05 % | Leerink Partners bestätigt Rating für Henry Schein bei Kursziel von 87 $ | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| ZIMMER BIOMET | 79,02 | -1,67 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board... ► Artikel lesen | |
| PETMED EXPRESS | 2,159 | -3,44 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results | Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for... ► Artikel lesen | |
| TANDEM DIABETES | 17,670 | -2,56 % | Tandem Diabetes care launches Mobi pump on Android phones | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| QUIDELORTHO | 16,900 | -1,17 % | QuidelOrtho präsentiert Wachstumsstrategie auf Raymond James Konferenz | ||
| QUEST DIAGNOSTICS | 173,05 | +0,06 % | Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer | Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a... ► Artikel lesen |